Rec­om­men­da­tions

2.23 Pa­tients should be screened after organ trans­plan­ta­tion for hy­per­glycemia, with a for­mal di­ag­no­sis of posttrans­plan­ta­tion di­a­betes mel­li­tus being best made once a pa­tient is sta­ble on an im­muno­sup­pres­sive reg­i­men and in the ab­sence of an acute in­fec­tion. E

2.24 The oral glu­cose tol­er­ance test is the pre­ferred test to make a di­ag­no­sis of posttrans­plan­ta­tion di­a­betes mel­li­tus. B

2.25 Im­muno­sup­pres­sive reg­i­mens shown to pro­vide the best out­comes for pa­tient and graft sur­vival should be used, irre­spective of posttrans­plan­ta­tion di­a­betes mel­li­tus risk. E